Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
décanoate d'halopéridol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
|
Haloperidol decanoate 50mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
|
Haloperidol 100mg injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
|
Haloperidol decanoate adverse reaction |
Causative agent (attribute) |
True |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |
allergie au décanoate d'halopéridol |
Causative agent (attribute) |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
|
allergie au décanoate d'halopéridol |
Causative agent (attribute) |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Haloperidol decanoate (substance) |
Inferred relationship |
Some |
1 |